A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
NCT ID: NCT04521023
Last Updated: 2020-08-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
132 participants
INTERVENTIONAL
2017-09-20
2020-06-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
NCT02651870
Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan
NCT03231982
Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension
NCT02944734
To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart Failure
NCT01682564
An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension
NCT02969265
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Cantabell Tab
Patients assigned to experimental group are treated with Cantabell Tab
B
Candemore Plus Tab
Patients assigned to experimental group are treated with Candemore Plus Tab
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cantabell Tab
Patients assigned to experimental group are treated with Cantabell Tab
Candemore Plus Tab
Patients assigned to experimental group are treated with Candemore Plus Tab
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Agreement with written informed consent
* Hypertensive Patients
Exclusion Criteria
* Participated in other trial within 30 days
* In investigator's judgement
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chong Kun Dang Pharmaceutical
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ajou University Hospital
Suwon, Gyeonggi-do, South Korea
Hallym Univ. Medical Center
Anyang, , South Korea
Daegu Catholic Univ. Medical Center
Daegu, , South Korea
MYONGJI Hospital
Goyang-si, , South Korea
Inje University Ilsan Paik Hospital
Ilsan-gu, , South Korea
Gachon University Gil Medical Center
Incheon, , South Korea
Jeju National University Hospital
Jeju City, , South Korea
Gangnam Severance Hospital
Seoul, , South Korea
Hallym University Kangnam Sacred Heart Hospital
Seoul, , South Korea
Hanyang University Medical Center
Seoul, , South Korea
Kangbuk Samsung Hospital
Seoul, , South Korea
SNU Boramae Medical Center
Seoul, , South Korea
Ulsan University Hospital
Ulsan, , South Korea
Wonju Severance Christian Hospital
Wŏnju, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
244HT16025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.